Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Impact of allergies on health-related quality of life in patients with asthma.

Sullivan PW, Kavati A, Ghushchyan VH, Lanz MJ, Ortiz B, Maselli DJ, LeCocq J.

J Asthma. 2019 Jul 16:1-16. doi: 10.1080/02770903.2019.1645168. [Epub ahead of print]

PMID:
31311356
2.

Healthcare resource utilization, expenditures, and productivity in patients with asthma with and without allergies.

Sullivan PW, Lanz MJ, Ghushchyan VH, Kavati A, LeCocq J, Ortiz B, Maselli DJ.

J Asthma. 2019 Jul 2:1-9. doi: 10.1080/02770903.2019.1628253. [Epub ahead of print]

PMID:
31264894
3.

Clinical Epidemiology of COPD: Insights From 10 Years of the COPDGene Study.

Maselli DJ, Bhatt SP, Anzueto A, Bowler RP, DeMeo DL, Diaz AA, Dransfield MT, Fawzy A, Foreman MG, Hanania NA, Hersh CP, Kim V, Kinney GL, Putcha N, Wan ES, Wells JM, Westney GE, Young KA, Silverman EK, Han MK, Make BJ.

Chest. 2019 May 30. pii: S0012-3692(19)31128-6. doi: 10.1016/j.chest.2019.04.135. [Epub ahead of print] Review.

PMID:
31154041
4.

Medication use and indicators of poor asthma control in patients with and without allergies.

Sullivan PW, Lanz MJ, Ghushchyan VH, Kavati A, LeCocq J, Ortiz B, Maselli DJ.

Allergy Asthma Proc. 2019 Jul 3;40(4):221-229. doi: 10.2500/aap.2019.40.4226. Epub 2019 May 3.

PMID:
31053178
5.

The lung mucosa environment in the elderly increases host susceptibility to Mycobacterium tuberculosis infection.

Moliva JI, Duncan MA, Olmo-Fontánez A, Akhter A, Arnett E, Scordo JM, Ault R, Sasindran SJ, Azad AK, Montoya MJ, Reinhold-Larsson N, Rajaram MVS, Merrit RE, Lafuse WP, Zhang L, Wang SH, Beamer G, Wang Y, Proud K, Maselli DJ, Peters J, Weintraub ST, Turner J, Schlesinger LS, Torrelles JB.

J Infect Dis. 2019 Mar 29. pii: jiz138. doi: 10.1093/infdis/jiz138. [Epub ahead of print]

PMID:
30923818
6.

Pulmonary vascular pruning in smokers with bronchiectasis.

Diaz AA, Maselli DJ, Rahaghi F, Come CE, Yen A, Maclean ES, Okajima Y, Martinez CH, Yamashiro T, Lynch DA, Wang W, Kinney GL, Washko GR, San José Estépar R.

ERJ Open Res. 2018 Nov 23;4(4). pii: 00044-2018. doi: 10.1183/23120541.00044-2018. eCollection 2018 Oct.

7.

Pooled RCTs: Adding LABAs to ICSs do not increase serious asthma events and reduce exacerbations.

Peters JI, Maselli DJ.

Ann Intern Med. 2018 Nov 20;169(10):JC53. doi: 10.7326/ACPJC-2018-169-10-053. No abstract available.

PMID:
30452560
8.

Benralizumab, an add-on treatment for severe eosinophilic asthma: evaluation of exacerbations, emergency department visits, lung function, and oral corticosteroid use.

Maselli DJ, Rogers L, Peters JI.

Ther Clin Risk Manag. 2018 Oct 23;14:2059-2068. doi: 10.2147/TCRM.S157171. eCollection 2018. Review.

9.

Asthma COPD overlap: Impact of associated comorbidities.

Maselli DJ, Hanania NA.

Pulm Pharmacol Ther. 2018 Oct;52:27-31. doi: 10.1016/j.pupt.2018.08.006. Epub 2018 Aug 30. Review.

PMID:
30172866
10.

Clinical Approach to the Therapy of Asthma-COPD Overlap.

Maselli DJ, Hardin M, Christenson SA, Hanania NA, Hersh CP, Adams SG, Anzueto A, Peters JI, Han MK, Martinez FJ.

Chest. 2019 Jan;155(1):168-177. doi: 10.1016/j.chest.2018.07.028. Epub 2018 Aug 2. Review.

PMID:
30077690
11.

Quadrupling inhaled glucocorticoid dose for deteriorating asthma control reduced severe exacerbations.

Maselli DJ, Peters JI.

Ann Intern Med. 2018 Jun 19;168(12):JC65. doi: 10.7326/ACPJC-2018-168-12-065. No abstract available.

PMID:
29913490
12.

Medication Regimens for Managing Acute Asthma.

Maselli DJ, Peters JI.

Respir Care. 2018 Jun;63(6):783-796. doi: 10.4187/respcare.05953. Review.

13.

In severe asthma, benralizumab reduced daily oral glucocorticoid dose and asthma exacerbations at 6 months.

Maselli DJ, Peters JI.

Ann Intern Med. 2017 Oct 17;167(8):JC43. doi: 10.7326/ACPJC-2017-167-8-043. No abstract available.

PMID:
29049762
14.

The Immunopathologic Effects of Mycoplasma pneumoniae and Community-acquired Respiratory Distress Syndrome Toxin. A Primate Model.

Maselli DJ, Medina JL, Brooks EG, Coalson JJ, Kannan TR, Winter VT, Principe M, Cagle MP, Baseman JB, Dube PH, Peters JI.

Am J Respir Cell Mol Biol. 2018 Feb;58(2):253-260. doi: 10.1165/rcmb.2017-0006OC.

15.

Inhaled Antibiotic Therapy in Chronic Respiratory Diseases.

Maselli DJ, Keyt H, Restrepo MI.

Int J Mol Sci. 2017 May 16;18(5). pii: E1062. doi: 10.3390/ijms18051062. Review.

16.

Suspecting non-cystic fibrosis bronchiectasis: What the busy primary care clinician needs to know.

Maselli DJ, Amalakuhan B, Keyt H, Diaz AA.

Int J Clin Pract. 2017 Feb;71(2). doi: 10.1111/ijcp.12924. Review.

17.

In refractory chronic cough, physiotherapy plus speech and language therapy improved quality of life at 4 weeks.

Maselli DJ, Peters JI.

Ann Intern Med. 2017 Jan 17;166(2):JC3. doi: 10.7326/ACPJC-2017-166-2-003. No abstract available.

PMID:
28114459
18.

Can Quality Improvement Initiatives With Organizational Changes Improve the Delivery of Asthma Care?

Habib SA, Maselli DJ.

Respir Care. 2016 Dec;61(12):1706-1707. No abstract available.

19.

Quantitative CT Measures of Bronchiectasis in Smokers.

Diaz AA, Young TP, Maselli DJ, Martinez CH, Gill R, Nardelli P, Wang W, Kinney GL, Hokanson JE, Washko GR, San Jose Estepar R.

Chest. 2017 Jun;151(6):1255-1262. doi: 10.1016/j.chest.2016.11.024. Epub 2016 Nov 24.

20.

Reslizumab in the management of poorly controlled asthma: the data so far.

Maselli DJ, Velez MI, Rogers L.

J Asthma Allergy. 2016 Aug 31;9:155-62. doi: 10.2147/JAA.S94164. eCollection 2016. Review.

21.

Bronchoarterial ratio in never-smokers adults: Implications for bronchial dilation definition.

Diaz AA, Young TP, Maselli DJ, Martinez CH, Maclean ES, Yen A, Dass C, Simpson SA, Lynch DA, Kinney GL, Hokanson JE, Washko GR, San José Estépar R.

Respirology. 2017 Jan;22(1):108-113. doi: 10.1111/resp.12875. Epub 2016 Aug 18.

22.

ACP Journal Club. Review: In COPD, tiotropium improves lung function and reduces adverse events compared with ipratropium bromide.

Maselli DJ, Peters JI.

Ann Intern Med. 2016 Jan 19;164(2):JC6. doi: 10.7326/ACPJC-2016-164-2-006. No abstract available.

PMID:
26784496
23.

Update in Bronchiectasis 2014.

Amalakuhan B, Maselli DJ, Martinez-Garcia MA.

Am J Respir Crit Care Med. 2015 Nov 15;192(10):1155-61. doi: 10.1164/rccm.201505-0926UP. No abstract available.

PMID:
26568240
24.

Profile of lebrikizumab and its potential in the treatment of asthma.

Maselli DJ, Keyt H, Rogers L.

J Asthma Allergy. 2015 Aug 10;8:87-92. doi: 10.2147/JAA.S69932. eCollection 2015. Review.

25.

ACP Journal Club. Review: Adding tiotropium to ICSs alone or with LABAs improves pulmonary function in asthma.

Maselli DJ, Peters JI.

Ann Intern Med. 2015 Jun 16;162(12):JC5. doi: 10.7326/ACPJC-2015-162-12-005. No abstract available.

PMID:
26075782
26.

Risk factors and antibiotic therapy in P. aeruginosa community-acquired pneumonia.

Sibila O, Laserna E, Maselli DJ, Fernandez JF, Mortensen EM, Anzueto A, Waterer G, Restrepo MI.

Respirology. 2015 May;20(4):660-6. doi: 10.1111/resp.12506. Epub 2015 Mar 16.

27.

Hospitalized exacerbations of COPD: risk factors and outcomes in the ECLIPSE cohort.

Müllerova H, Maselli DJ, Locantore N, Vestbo J, Hurst JR, Wedzicha JA, Bakke P, Agusti A, Anzueto A.

Chest. 2015 Apr;147(4):999-1007. doi: 10.1378/chest.14-0655.

PMID:
25356881
28.

Incidence and aetiologies of pulmonary granulomatous inflammation: a decade of experience.

Nazarullah A, Nilson R, Maselli DJ, Jagirdar J.

Respirology. 2015 Jan;20(1):115-21. doi: 10.1111/resp.12410. Epub 2014 Oct 29.

29.

Impact of macrolide therapy in patients hospitalized with Pseudomonas aeruginosa community-acquired pneumonia.

Laserna E, Sibila O, Fernandez JF, Maselli DJ, Mortensen EM, Anzueto A, Waterer G, Restrepo MI.

Chest. 2014 May;145(5):1114-1120. doi: 10.1378/chest.13-1607.

30.

Airway hyperresponsiveness is associated with airway remodeling but not inflammation in aging Cav1-/- mice.

Gabehart KE, Royce SG, Maselli DJ, Miyasato SK, Davis EC, Tang ML, Jourdan Le Saux C.

Respir Res. 2013 Oct 21;14:110. doi: 10.1186/1465-9921-14-110.

31.

5 days of prednisone was noninferior to 14 days in patients with acute COPD exacerbation.

Maselli DJ, Peters JI.

Ann Intern Med. 2013 Sep 17;159(6):JC5. doi: 10.7326/0003-4819-159-6-201309170-02005. No abstract available.

PMID:
24042388
32.

Efficacy of omalizumab in asthmatic patients with IgE levels above 700 IU/mL: a retrospective study.

Maselli DJ, Singh H, Diaz J, Peters JI.

Ann Allergy Asthma Immunol. 2013 Jun;110(6):457-61. doi: 10.1016/j.anai.2013.04.011.

PMID:
23706716
33.

Safety of β-blockers in the acute management of cocaine-associated chest pain.

Ibrahim M, Maselli DJ, Hasan R.

Am J Emerg Med. 2013 Jun;31(6):989. doi: 10.1016/j.ajem.2013.02.022. Epub 2013 May 13. No abstract available.

PMID:
23680320
34.

Safety of β-blockers in the acute management of cocaine-associated chest pain.

Ibrahim M, Maselli DJ, Hasan R.

Am J Emerg Med. 2013 Jun;31(6):987-8. doi: 10.1016/j.ajem.2013.02.026. Epub 2013 Apr 17. No abstract available.

PMID:
23602746
35.

Can respiratory therapist-driven protocols improve resource utilization?

Maselli DJ, Fernandez JF.

Respir Care. 2013 Mar;58(3):546-7. doi: 10.4187/respcare.02353. No abstract available.

36.

Management of asthma during pregnancy.

Maselli DJ, Adams SG, Peters JI, Levine SM.

Ther Adv Respir Dis. 2013 Apr;7(2):87-100. doi: 10.1177/1753465812464287. Epub 2012 Nov 5. Review.

PMID:
23129568
37.

Safety of β-blockers in the acute management of cocaine-associated chest pain.

Ibrahim M, Maselli DJ, Hasan R, Hamilton A.

Am J Emerg Med. 2013 Mar;31(3):613-6. doi: 10.1016/j.ajem.2012.09.027. Epub 2012 Oct 30.

PMID:
23122421
38.

Pulmonary mucormycosis: what is the best strategy for therapy?

Fernandez JF, Maselli DJ, Simpson T, Restrepo MI.

Respir Care. 2013 May;58(5):e60-3. doi: 10.4187/respcare.02106. No abstract available.

39.

Computed tomography imaging for Mycobacterium xenopi infections, a clearer path for diagnosis?

Maselli DJ, Fernandez JF.

Respirology. 2013 Jan;18(1):1-2. doi: 10.1111/resp.12001. No abstract available.

40.

The need to further understand who gets hospitalized for a COPD exacerbation.

Maselli DJ, Anzueto A.

Multidiscip Respir Med. 2012 Jun 19;7(1):7. doi: 10.1186/2049-6958-7-7. No abstract available.

41.

Lung transplant infection.

Burguete SR, Maselli DJ, Fernandez JF, Levine SM.

Respirology. 2013 Jan;18(1):22-38. doi: 10.1111/j.1440-1843.2012.02196.x. Review.

42.

Clinical evaluation of the role of ceftaroline in the management of community acquired bacterial pneumonia.

Maselli DJ, Fernandez JF, Whong CY, Echevarria K, Nambiar AM, Anzueto A, Restrepo MI.

Infect Drug Resist. 2012;5:43-51. doi: 10.2147/IDR.S17433. Epub 2012 Feb 1.

43.

Pulmonary hypertension as a risk factor for graft dysfunction, ultrasound-guided subclavian vein cannulation, and lebrikizumab for adult asthma.

Burguete SR, Fernandez JF, Maselli DJ.

Am J Respir Crit Care Med. 2012 Jan 15;185(2):223-4. doi: 10.1164/rccm.201109-1651RR. No abstract available.

PMID:
22246703
44.

The role of anti-infectives in the treatment of refractory asthma.

Maselli DJ, Adams S, Peters J.

Ther Adv Respir Dis. 2011 Dec;5(6):387-96. doi: 10.1177/1753465811402534. Epub 2011 Apr 1. Review.

PMID:
21459926
45.

Strategies in the prevention of ventilator-associated pneumonia.

Maselli DJ, Restrepo MI.

Ther Adv Respir Dis. 2011 Apr;5(2):131-41. doi: 10.1177/1753465810395655. Epub 2011 Feb 7. Review.

PMID:
21300737

Supplemental Content

Loading ...
Support Center